$VYX

NCR Voyix: Q2 Earnings Snapshot

NCR Voyix (VYX) reported Q2 earnings of $2 million and a net loss of 1 cent per share. Adjusted earnings were 17 cents per share, and revenue was $523 million. The company expects full-year earnings of 89 to 92 cents per share and revenue of $2.19 billion to $2.3 billion.

Original reporting
Published Aug 5, 2026, 10:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 11:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$VYX
Neutral
medium confidence
Mentioned
$VYX
Relevance
8/10
AlphAI data visualization · based on local3news.com
Decision brief

The 30-second read

$VYXNeutralMed
01

Why it matters

Fresh Q2 performance and explicit full-year EPS and revenue guidance can change expectations for FY profitability and growth trajectory.

02

Market read

Traders can update FY models using the provided EPS and revenue ranges and reassess valuation and positioning into subsequent quarters.

03

What to watch

The article omits segment detail, cash flow, and order/backlog commentary, which often matter more than headline revenue/EPS for this business model.

Relevance 8/10Novelty 7/10Timing: reported Wednesday after market close or during the day (published 2026-08-05 22:15 UTC)

Background

AP earnings snapshot for NCR Voyix covering Q2 results and full-year outlook.

Company-level read

Ticker impact

$VYXNeutralMedium confidence
Context

NCR Voyix reported Q2 results and issued full-year EPS guidance of $0.89 to $0.92 and revenue of $2.19B to $2.3B.

Expected impact

Likely modest volatility around the guidance range, with direction dependent on how it compares to Street estimates.

Evidence & confidence

It includes both reported Q2 metrics (revenue, EPS) and explicit full-year guidance ranges, which are typically the key drivers for earnings-day positioning.

Market effects

ATM and payments hardware/software providers may see read-through on demand and spending expectations for payment infrastructure.

Limited, as the disclosure is company-specific with no broader regional macro signal.

Low, unless guidance indicates a broader payments capex cycle shift.

Counterpoint

Guidance ranges can be conservative; traders may fade the initial reaction if the company’s margins or backlog trends are not discussed.

Key entities

  • NCR Voyix Corporation

    Maker of ATMs and payments hardware and software; reported Q2 results and provided full-year guidance.

Related articles

$VYXMed

NCR Voyix Q2 Earnings Call Highlights

NCR Voyix (NYSE:VYX) reported Q2 progress on enterprise platform transformations, including a remote Voyix POS installation for a large European grocery retailer completed in about half the usual time. Retail signed 40+ customers; retail revenue fell 20% to $365M due to hardware transition, but adjusted EBITDA rose 20% to $97M. Restaurant revenue fell 23% to $158M. Non-GAAP EPS was $0.17. Full-year 2026 outlook maintained: revenue $2.188B-$2.303B, adj EBITDA $432M-$447M, EPS $0.89-$0.92.

$VYXMed

NCR Voyix Corp (VYX): Completion of Acquisition or Disposition of Assets

NCR Voyix Corp (VYX) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. NEWS RELEASE NCR Voyix Reports Second Quarter 2026 Results ATLANTA, August 5, 2026 - NCR Voyix Corporation (NYSE: VYX) (“NCR Voyix” or the “Company”), a platform-powered leader in unified commerce for shopping and dining, reported financial results today for the three and six mon

$TSLAMedAI 8/10

Good News for Tesla Investors: 3 Key Benchmarks Elon Musk's Company Delivered On in the Third Quarter

Tesla reported Q3 earnings, highlighting improved automotive gross margins (18.3%), reduced capex forecasts (~$20B), and progress on Robotaxi rollout. CEO Elon Musk noted strong demand. CFO Vaibhav Taneja addressed cash flow concerns, easing investor worries. The company remains on track with its full self-driving (FSD) software v15 release, expected in Q1 or Q2 2024.

$BBDMed

Bank Bradesco SA (BBD) (Q3 2026) Earnings Call Highlights: Resilient Profit Growth

Bank Bradesco SA (BBD) reported Q3 2026 earnings with resilient profit growth but faced pressures on net interest margin (NIM) due to corporate mix and higher cost of risk. Over-90-day NPLs rose to 4.6%, driven by FGI/FGO portfolios and John Deere Bank seasonality. CEO Marcelo Noronha expects NIM improvement in Q4 2026 but acknowledges macroeconomic challenges. The bank is reducing exposure to high-risk personal loans and credit cards.

$RDYMed

Dr Reddy's Laboratories Ltd (RDY) (Q2 2027) Earnings Call Highlights: Margin Recovery

Dr. Reddy's Laboratories reported a 1.5% year-over-year revenue decline, driven by lower lenalidomide sales and declines in North America, Europe, and PSAI businesses. The company expects margins to improve with new products and business mix, targeting a 55% gross margin. Semaglutide relaunch is planned for November 2026, and abatacept biosimilar approval is expected by December 2026.

$BCSMedAI 8/10

Barclays Posts £2.3bn Q3 Profit and Plans 5,000 Job Cuts

Barclays reported a 12% rise in Q3 pre-tax profit to £2.3bn, driven by revenue growth and lower impairment charges. The bank announced a £500m share buyback and plans to cut 5,000 jobs. Revenue increased 3% to £7.4bn, while earnings per share rose 18%. Trading revenues showed mixed results, with equities up 47% and fixed income down 19%. Shares fell over 2.5% post-announcement.